ePosters
Neuropathic pain is one of the most difficult pain syndromes to manage. It presents a significant healthcare burden, particularly given inadequacies of existing treatments. First-line medications like gabapentinoids deliver inconsistent analgesia and are often poorly tolerated [1].
Lidocaine shows promise for neuropathic pain. Studies demonstrate that lidocaine infusions are more effective than placebo [2,3]. However, comparisons with standard of care therapies remain limited. This study compares the efficacy and tolerability of lidocaine infusions versus gabapentinoids.
William Kindschuh, M.D., Ph.D.
Resident
Columbia University, United States
David Agbato, B.S.
Student
The City University of New York, United States
Dante Mueller, B.S.
Student
Columbia University, United States
Andrew Aboujaoude, M.D., Capt.
Resident
Columbia University
New York, New York, United States
Melissa Chao, M.D.
Assistant Professor
Columbia University, United States
Leena Mathew, M.D. (she/her/hers)
Professor
Columbia University
New York , New York, United States